Mount Sinai Launches New Institute for Health Equity Research

Newswise — (New York, NY – May 14, 2020) The Mount Sinai Health System (MSHS) today announced the creation of a new Institute for Health Equity Research (IHER) to understand the effects of health issues including COVID-19, affecting at-risk communities including those that are non-white, low-income, immigrant, uninsured, and LGBTQ+ across all ages, genders and abilities. The United States now has by far the most reported COVID-19 cases and deaths worldwide, and the immediate and long-term effects on the health of these at-risk groups are still not quantified. The disproportionate impact in underserved populations has highlighted the importance of rigorously studying disparities, and translating discoveries into sustainable, scalable initiatives and policies that benefit communities in New York and the nation.

With philanthropic support from the Mount Sinai Boards of Trustees, the IHER will quickly identify the root causes and magnitude of disparities, devise and test innovative solutions, and take concrete action in response to findings. Richard A. Friedman, Co-Chairman, of the Mount Sinai Boards of Trustees will chair a newly formed IHER Task Force that will guide, publicize, and inform on the research underway.

IHER Task Force members include:

  • New York State Senator Brian Benjamin (Harlem/Upper West Side);
  • Martin Chavez, former Chief Financial Officer at Goldman Sachs & Co.;
  • Edith Cooper, former Managing Director and Global Head of Human Capital Management at Goldman Sachs & Co.;
  • Margaret Crotty, CEO of Partnership with Children;
  • Kimberley Harris, Executive Vice President of Comcast Corporation and General Counsel of NBC Universal;
  • Mellody Hobson, Co-CEO and President of Ariel Investments;
  • Earvin “Magic” Johnson, five-time NBA champion and Chairman and CEO of the Magic Johnson Enterprises;
  • Pablo Legorreta, founder and Chief Executive Officer of Royalty Pharma;
  • Lisa Opoku, Global Chief Operating Officer for Engineering at Goldman Sachs & Co.;
  • Jodie Patterson, author and LGBTQAI advocate;
  • Ruth Simmons, PhD, President of Prairie View A&M University.

“This pandemic has disproportionately affected communities of color across our country,” said Earvin “Magic” Johnson, IHER task force member. “We must understand ‘the why’ in order to prevent further deaths. In addition, we need to address systemic healthcare inequities in the minority communities that have been prevalent throughout history. I am pleased to be a part of this task force and encourage others to join us in support of these efforts.”

Carol Horowitz, MD, MPH, Professor of Population Health Science and Policy, Professor of Medicine, and Dean for Gender Equity in Science and Medicine at Icahn School of Medicine at Mount Sinai (ISMMS), will direct the new Institute, and Lynne Richardson, MD, Professor of Emergency Medicine, and Population Health Science and Policy, and Vice Chair for Academic, Research and Community Programs at ISMMS, will be Co-Director.

A transdisciplinary team of health equity researchers will develop a community-based, community-focused network to generate vital information about priority populations devastated by the pandemic and other chronic illnesses, collecting real-time data on those who are most at risk and whose challenges remain largely unrecognized. One of the first projects is “Speak Up on COVID-19” - an 11-language survey in partnership with over 100 New York City community organizations. “Speak Up” will explore medical, demographic, social determinants, and COVID-19-related attitudinal, behavioral, and psychological factors; capture risks and needs; and link these populations with resources that sustain physical and mental health.

“The IHER will not only enhance and guide Mount Sinai’s ability to combat the current COVID-19 pandemic but will also strengthen and illuminate disparities research underway and train the next generation of diversity scholars. Our extensive expertise in population health and serving one of the most socioeconomically, demographically, and culturally varied populations in the world, make us uniquely positioned to take on this enormous challenge,” said Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of ISMMS and President for Academic Affairs for MSHS. “The war against this pandemic and the threat to underserved communities is great. We will not rest until we defeat it on many fronts: scientific, clinical, and public health.”

“In many communities, COVID-19 has been extra-lethal because it is a pandemic piling on top of multiple, preexisting epidemics: black and Latinx communities already bear an uneven burden of high blood pressure, asthma, diabetes, heart disease and premature death,” said Carol Horowitz, MD, MPH, Professor of Population Health Science and Policy, Dean for Gender Equity in Science and Medicine and Director of the new Institute. “These communities tend to have poorer access to care and information about health issues like COVID-19, less opportunity for social distancing, overcrowded home situations, and the most precarious economic circumstances.”

“We’re entering a new normal way of life, and IHER will focus on health disparity issues that can no longer be ignored,” says Mr. Friedman. “I’m proud of Mount Sinai’s willingness to take on this initiative to serve our community.”

Studies currently underway in COVID-19 and other areas include:

  • The interaction of race, ethnicity, disability, underlying illnesses, and social determinants including poverty, pollution, and household crowding on hospitalization and death from COVID-19;
  • The impact of gender-affirming hormone treatment on the clinical course of COVID-19 in transgender and gender nonbinary patients;
  • Health outcomes for those living with HIV and COVID-19;
  • How patient care via telehealth can be delivered equitably and narrow the digital divide; and
  • Translating scientific discoveries into routine use for diverse populations, including using genetic testing to inform choice and dose of antidepressants and pain medications.

Mount Sinai’s deep expertise in healthcare delivery research will provide a lens for how we provide care and identify opportunities to improve equity for the diverse communities we serve. 

### 

Support Mount Sinai’s COVID-19 Response: Join us in this extraordinary and continuing fight against the COVID-19 pandemic and for health equity. Donate now to support our frontline clinicians who are caring for critically ill patients and our researchers who are furthering understanding of the virus, developing therapies, and addressing the wide-ranging impacts of the pandemic.  Visit www.giving.mountsinai.org

About the Mount Sinai Health System: The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine at Mount Sinai (ISMMS) as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report. For more information, visit mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.




Filters close

Showing results

110 of 3468
Released: 1-Oct-2020 9:40 AM EDT
Scientists at Texas Biomed develop new tool to aid in the development of SARS-CoV-2 antivirals and vaccines
Texas Biomedical Research Institute

Researchers apply a novel reverse genetics approach to create recombinant SARS-CoV-2San Antonio, Texas (October 1, 2020) – Researchers at Texas Biomedical Research Institute (Texas Biomed) recently published findings from an innovative SARS-CoV-2 study that will assist in the development of new vaccines and antivirals for COVID-19.

Released: 1-Oct-2020 9:30 AM EDT
COVID-19 Study Retractions Drive Research Transparency Partnership and Push for Increased Publication of Negative/Null Findings
Wolters Kluwer Health

Together, The Center for Biomedical Research Transparency (CBMRT), the American Heart Association (AHA) and Wolters Kluwer continue to address the issue of publication bias – and the importance of publishing research with negative findings – by launching the Null Hypothesis Initiative for all of the AHA's 12 peer-reviewed, scientific research journals.

Released: 1-Oct-2020 8:20 AM EDT
The GovLab and the IDB bring innovative ideas to Latin American government officials
New York University

The Governance Lab at New York University’s Tandon School of Engineering and the Inter-American Development Bank (IDB) share the results of the first two “Smarter Crowdsourcing in the Age of Coronavirus” online sessions

Released: 1-Oct-2020 8:15 AM EDT
How (and Why) Steak-umm Became a Social Media Phenomenon During the Pandemic
North Carolina State University

A new study outlines how a brand of frozen meat products took social media by storm – and what other brands can learn from the phenomenon.

Released: 1-Oct-2020 5:05 AM EDT
Relationships at home during the COVID-19 pandemic continue to improve, reports USC Center for the Digital Future
USC Annenberg School for Communication and Journalism

In spite of the stress from COVID-19 and stay-at-home restrictions, many Americans continue to say the relationships with their spouses and children have improved during the pandemic, a study by the USC Center for the Digital Future (CDF) has found.

28-Sep-2020 5:20 PM EDT
Leading Argonne Scientists Discuss Latest Research on Cybersecurity During the COVID-19 Pandemic
Argonne National Laboratory

Hear firsthand from two of the U.S. Department of Energy’s Argonne National Laboratory’s scientific leaders how their research provides insight into cyber resilience and cybersecurity to help secure our nation’s information and systems.

Newswise: Computer Model Shows How COVID-19 Could Lead to Runaway Inflammation
Released: 30-Sep-2020 9:05 PM EDT
Computer Model Shows How COVID-19 Could Lead to Runaway Inflammation
Cedars-Sinai

New research from the University of Pittsburgh and Cedars-Sinai digs into the question: Why do some people with COVID-19 develop severe inflammation? The study is published in the Proceedings of the National Academy of Sciences.

Newswise: Cardiac Arrest, Poor Survival Rates Common in Sickest Patients with COVID-19
29-Sep-2020 5:05 PM EDT
Cardiac Arrest, Poor Survival Rates Common in Sickest Patients with COVID-19
Michigan Medicine - University of Michigan

Study shows critically ill patients with the novel coronavirus have high rates of cardiac arrest and poor outcomes even after CPR, an effect most strongly seen in older patients.

Newswise: 244463_web.jpg
Released: 30-Sep-2020 3:45 PM EDT
Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.

Newswise: Tufts University to lead $100M program to reduce risk of zoonotic viral spillover, spread
Released: 30-Sep-2020 2:10 PM EDT
Tufts University to lead $100M program to reduce risk of zoonotic viral spillover, spread
Tufts University

Tufts University will lead a $100 million, five-year program to understand and address threats posed by zoonotic viral diseases that can “spill over” from animals to humans, such as SARS-CoV-2, in an effort to reduce risk of infection, amplification, and spread, USAID announced today.


Showing results

110 of 3468

close
1.124